Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 4 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Monoclonal gammopathy of uncertain significance.
Med Clin (Barc). 2023 Sep 8;161(5):217-224. doi: 10.1016/j.medcli.2023.05.006. Epub 2023 Jun 15.
Med Clin (Barc). 2023.
PMID: 37330390
Review.
English, Spanish.
Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients.
Puertas B, González-Calle V, Sureda A, Moreno MJ, Oriol A, González E, Rosiñol L, López J, Escalante F, Martínez-Lopez J, Carrillo E, Clavero E, Ríos-Tamayo R, Rey-Bua B, González-Rodríguez AP, Dourdil V, De Arriba F, González S, Pérez-de-Oteyza J, Hernández MT, García-Mateo A, Bargay J, Bladé J, Lahuerta JJ, San Miguel JF, Ocio EM, Mateos MV.
Puertas B, et al.
Haematologica. 2023 Oct 1;108(10):2753-2763. doi: 10.3324/haematol.2022.282490.
Haematologica. 2023.
PMID: 37102598
Free PMC article.
Clinical Trial.
Item in Clipboard
Anti-BCMA CAR T-cell Therapy: Changing the Natural History of Multiple Myeloma.
Puertas B, Mateos MV, González-Calle V.
Puertas B, et al.
Hemasphere. 2022 Feb 15;6(3):e691. doi: 10.1097/HS9.0000000000000691. eCollection 2022 Mar.
Hemasphere. 2022.
PMID: 35187407
Free PMC article.
No abstract available.
Item in Clipboard
Multiple myeloma with t(11;14): impact of novel agents on outcome.
Puertas B, González-Calle V, Sobejano-Fuertes E, Escalante F, Rey-Bua B, Padilla I, García-Sanz R, Puig N, Gutiérrez NC, Mateos MV.
Puertas B, et al.
Blood Cancer J. 2023 Mar 20;13(1):40. doi: 10.1038/s41408-023-00807-9.
Blood Cancer J. 2023.
PMID: 36935422
Free PMC article.
Item in Clipboard
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma.
Puertas B, González-Calle V, Sobejano-Fuertes E, Escalante F, Queizán JA, Bárez A, Labrador J, Alonso-Alonso JM, García de Coca A, Cantalapiedra A, Villaescusa T, Aguilar-Franco C, Alejo-Alonso E, Rey-Bua B, López-Corral L, García-Sanz R, Puig N, Gutiérrez NC, Mateos MV.
Puertas B, et al.
Cancers (Basel). 2023 Mar 2;15(5):1558. doi: 10.3390/cancers15051558.
Cancers (Basel). 2023.
PMID: 36900349
Free PMC article.
Item in Clipboard
A research center's experience of T-cell redirecting therapies in triple-class refractory multiple myeloma.
Puertas B, Fernández-Sánchez A, Alejo E, Rey-Bua B, Martín-López AÁ, Pérez López E, Lopez-Parra M, Lopez-Corral L, Gutierrez NC, García-Sanz R, Puig N, Gonzalez-Calle V, Mateos MV.
Puertas B, et al.
Blood Adv. 2024 May 8:bloodadvances.2024012773. doi: 10.1182/bloodadvances.2024012773. Online ahead of print.
Blood Adv. 2024.
PMID: 38717869
Item in Clipboard
Cite
Cite